James Roach

1.6k citations

35 papers · 1.1k indexed · h-index 18

Impact in

Endocrine and Autonomic Systems top 5%
- Circadian rhythm and melatonin
Experimental and Cognitive Psychology top 5%
- Sleep and related disorders

Papers in ⓘ

Endocrine and Autonomic Systems 5
- Neuroscience of respiration and sleep 4
Internal Medicine 2

Co-authors: David A. Amato (3 shared papers)Robert Rubens (4 shared papers)Kendyl Schaefer (5 shared papers)Thomas Roth (3 shared papers)Yancy Y. Phillips (5 shared papers)Gregory J. Argyros (4 shared papers)Andrew D. Krystal (2 shared papers)V. Alin Botoman (1 shared paper)
Journals: CHEST Journal (7 papers)Journal of Clinical Oncology (4 papers)Sleep Medicine (1 paper)Journal of Pediatric Orthopaedics (1 paper)Annals of the Rheumatic Diseases (1 paper)
Partner nations: United States United Kingdom Canada

In The Last Decade

James Roach

35 papers receiving 1.1k citations

Peers

Countries citing papers authored by James Roach

Since Specialization

Citations

This map shows the geographic impact of James Roach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Roach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Roach more than expected).

Fields of papers citing papers by James Roach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Roach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Roach. The network helps show where James Roach may publish in the future.

Co-authors

The 25 scholars most cited alongside James Roach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James Roach Line = papers co-authored together James Roach links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Nightly Treatment of Primary Insomnia With Eszopiclone for Six Months: Effect on Sleep, Quality of Life, and Work Limitations SLEEP ·James K. Walsh, Andrew D. Krystal, David A. Amato, Robert Rubens, Judy Caron, Thomas Wessel, Kendyl Schaefer, James Roach, Gene V. Wallenstein, Thomas Roth	2007	167
2	Portal colopathy: Prospective study of colonoscopy in patients with portal hypertension Gastroenterology ·Richard A. Kozarek, V. Alin Botoman, James E. Bredfeldt, James Roach, David J. Patterson, Terrance J. Ball	1991	106
3	Eszopiclone Coadministered With Escitalopram in Patients With Insomnia and Comorbid Generalized Anxiety Disorder Archives of General Psychiatry ·Mark H. Pollack, Gustavo Kinrys, Andrew D. Krystal, W. Vaughn McCall, Thomas Roth, Kendyl Schaefer, Robert Rubens, James Roach, Holly Huang, Ranga Krishnan	2008	104
4	The Effects of Heparins on the Liver: Application of Mechanistic Serum Biomarkers in a Randomized Study in Healthy Volunteers Clinical Pharmacology & Therapeutics ·Alison H. Harrill, James Roach, Ian Fier, J. Scott Eaddy, C. Lisa Kurtz, Daniel J. Antoine, Diane M Spencer, Takashi Kishimoto, David S. Pisetsky, B K Park, Paul B. Watkins	2012	89
5	Eucapnic Voluntary Hyperventilation as a Bronchoprovocation Technique CHEST Journal ·Gregory J. Argyros, James Roach, Kenneth M. Hurwitz, Am H. Eliasson, Yancy Y. Phillips	1996	74
6	A pilot study evaluating acute use of eszopiclone in patients with mild to moderate obstructive sleep apnea syndrome Sleep Medicine ·Russell Rosenberg, James Roach, Martin B. Scharf, David A. Amato	2007	71
7	Interpretation of Eucapnic Voluntary Hyperventilation in the Diagnosis of Asthma CHEST Journal ·Kenneth M. Hurwitz, Gregory J. Argyros, James Roach, Arn H. Eliasson, Yancy Y. Phillips	1995	58
8	Phase I study of Aplidine in a daily×5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115 Annals of Oncology ·J. Maroun, K. Bélanger, Lesley Seymour, S. Matthews, James Roach, Jeanne Dionne, Denis Soulières, David J. Stewart, Rakesh Goel, Danielle Charpentier, Glenwood Goss, Eva Tomiak, J. Yau, José Jimeno, G. Chiritescu	2006	51
9	Levalbuterol compared with racemic albuterol in the treatment of acute asthma: results of a pilot study The American Journal of Emergency Medicine ·Richard M. Nowak, Charles L. Emerman, Kendyl Schaefer, Rachel L DiSantostefano, Louis Vaickus, James Roach	2004	38
10	Right Upper Lobe Pulmonary Edema Caused by Acute Mitral Regurgitation CHEST Journal ·James Roach, Karl C. Stajduhar, Kenneth G. Torrington	1993	37
11	Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab-Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I Results The Oncologist ·Eileen M. O’Reilly, James Roach, Paul Miller, Kenneth H. Yu, Catherine Tjan, Molly Rosano, Silva Krause, William Avery, Julie Wolf, Keith T. Flaherty, Darrell Nix, David P. Ryan	2017	36
12	The Effect of Eszopiclone in Patients With Insomnia and Coexisting Rheumatoid Arthritis The Primary Care Companion to The Journal of Clinical Psychiatry ·Thomas Roth, J. M. Price, David A. Amato, Robert Rubens, James Roach, Thomas J. Schnitzer	2009	33
13	Next‐day cognition, psychomotor function, and driving‐related skills following nighttime administration of eszopiclone Human Psychopharmacology Clinical and Experimental ·Julia Boyle, Leanne Trick, Sigurd Johnsen, James Roach, Robert Rubens	2008	33
14	Development of Glatopa® (Glatiramer Acetate): The First FDA-Approved Generic Disease-Modifying Therapy for Relapsing Forms of Multiple Sclerosis Journal of Pharmacy Practice ·Christine Bell, James Anderson, Tanmoy Ganguly, James L. Prescott, Ishan Capila, Jonathan C. Lansing, Richard A. Sachleben, Mani Iyer, Ian Fier, James Roach, Kristina Storey, Paul Miller, Steven C. Hall, Daniel Kantor, Benjamin Greenberg, Kavita Nair, Joseph L. Glajch	2017	31
15	Evaluation of the Safety and Efficacy of Levalbuterol in 2-5-year-Old Patients with Asthma Pediatric Pulmonology ·David P. Skoner, Leon S. Greos, Kenneth T. Kim, James Roach, Merdad V. Parsey, Rudolf A. Baumgartner, (unknown)	2005	29
16	Randomised phase II trial of gemcitabine and nab-paclitaxel with necuparanib or placebo in untreated metastatic pancreas ductal adenocarcinoma European Journal of Cancer ·Eileen M. O’Reilly, Diletta Barone, Devalingam Mahalingam, Tanios Bekaii‐Saab, Spencer H. Shao, Julie Wolf, Molly Rosano, Silva Krause, Donald Richards, Kenneth H. Yu, James Roach, Keith T. Flaherty, David P. Ryan	2020	27
17	A phase 1/1b study of PUR1900, an inhaled formulation of itraconazole, in healthy volunteers and asthmatics to study safety, tolerability and pharmacokinetics British Journal of Clinical Pharmacology ·David L. Hava, Lisa Tan, Patrick W. Johnson, Aidan K. Curran, Jason K. Perry, Steve Kramer, Katie Kane, Pauline Bedwell, Gary Layton, Clarie Swann, Dennis R. Henderson, Naimat Ullah Khan, Lucy Connor, Litza McKenzie, Dave Singh, James Roach	2019	23
18	Evaluation of a New Heparin Agent in Percutaneous Coronary Intervention Circulation ·Sunil V. Rao, Chiara Melloni, Shelley Myles-DiMauro, Samuel Broderick, Andrzej S. Kosinski, Neal S. Kleiman, Vladimír Džavík, Jean François Tanguay, Harish Chandna, Roger Gammon, Ernesto Rivera, John H. Alexander, Ian Fier, James Roach, Richard C. Becker	2010	19
19	Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: A 2-week, multicenter, randomized, open-label study Clinical Therapeutics ·James F. Donohue, Nicola A. Hanania, Ronald L. Ciubotaru, Les Noe, David J. Pasta, Kendyl Schaefer, R. Claus, William H. Andrews, James Roach	2008	15
20	Pairwise comparison of levalbuterol versus racemic albuterol in the treatment of moderate-to-severe asthma. PubMed ·Warren Pleskow, Harold S. Nelson, Kendyl Schaefer, Raymond Claus, James Roach	2005	15

About James Roach

James Roach is a scholar working on Endocrine and Autonomic Systems, Internal Medicine, Physiology, Pulmonary and Respiratory Medicine and Experimental and Cognitive Psychology, having authored 35 papers that have together received 1.1k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (10 papers), Respiratory and Cough-Related Research (8 papers), Cancer Treatment and Pharmacology (5 papers), Pancreatic and Hepatic Oncology Research (5 papers), Sleep and related disorders (5 papers), Neuroscience of respiration and sleep (4 papers), Sleep and Wakefulness Research (4 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). The work is most often cited by research in Endocrine and Autonomic Systems (175 citations), Experimental and Cognitive Psychology (322 citations), Cognitive Neuroscience (279 citations), Hepatology (108 citations) and Physiology (311 citations). James Roach has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include David A. Amato, Robert Rubens, Kendyl Schaefer, Thomas Roth, Yancy Y. Phillips, Gregory J. Argyros, Andrew D. Krystal, V. Alin Botoman, Richard A. Kozarek and James E. Bredfeldt. Their work appears in journals such as CHEST Journal, Journal of Clinical Oncology, Sleep Medicine, Journal of Pediatric Orthopaedics and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact